Press Release
Lantheus Continues to Commend CMS’ CY25 Rule to Enhance Payment for Specialized Diagnostic Radiopharmaceuticals and Reaffirms Outlook for PYLARIFY’s Blockbuster Status for 2025
November 11, 2024
Read More at Our Investor SiteWe do it by making a difference in the lives of our patients. Stay current with the latest news, information and events at Lantheus. Please visit our investor site for a complete list of recent and archived press releases. Follow us on LinkedIn and X for social media updates.
For media resources, including images, logos, videos, and more, browse our media library.
Press Release
November 11, 2024
Read More at Our Investor SitePress Release
November 6, 2024
Read More at Our Investor SitePress Release
November 4, 2024
Read More at Our Investor Site